Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

Recruiting

Phase N/A Results N/A

Summary of Purpose

To describe the treatment perception from patients with non-valvular atrial fibrillation (NVAF) receiving Pradaxa® or VKA for stroke prevention by using the self-estimation questionnaire of PACT-Q during a 6-month study period.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 October 2017.

20 Jun 2017 13 Jun 2017 9 Aug 2018 29 Mar 2019 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts

  • Boehringer Ingelheim